title: Cloudy dialysate and pseudomembranous colitis in a patient on CAPD.
authors: First Department of Medicine Division of Blood Purification Hamamatsu University School of Medicine, Hamamatsu Department of Internal Medicine Fujinomiya City General Hospital, Fujinomiya Shizuoka, Japan.
authors: Y
authors: Y
authors: Sakao
authors: A
authors: A
authors: Kato
authors: T
authors: T
authors: Sugiura
authors: T
authors: T
authors: Fujikura
authors: T
authors: T
authors: Misaki
authors: T
authors: T
authors: Tsuji
authors: M
authors: M
authors: Sakakima
authors: H
authors: H
authors: Yasuda
authors: Y
authors: Y
authors: Fujigaki
authors: A
authors: A
authors: Hishida
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002097:C-Reactive Protein / Q000032:analysis; D002442:Ceftazidime / Q000009:adverse effects; D015897:Comorbidity; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced / Q000175:diagnosis* / Q000453:epidemiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
chemical_list: D000900:Anti-Bacterial Agents; D002097:C-Reactive Protein; D002442:Ceftazidime